Why are so few antipsychotic drugs licensed for Alzheimer's disease related behavioral and psychological symptoms?
- PMID: 31282774
- DOI: 10.1080/14737175.2019.1641407
Why are so few antipsychotic drugs licensed for Alzheimer's disease related behavioral and psychological symptoms?
Keywords: Alzheimer’s disease; antipsychotic drugs; behavioral and psychological symptoms; nonpharmacological therapy; pharmacological therapy; safety.
Publication types
LinkOut - more resources
Full Text Sources